Difficulty: Medium
Average Score: 76%
Practice
The treatment of choice for the patient in Questions 11 and 12 is
Correct answer
B
Rationale
Bromocriptine (B), a dopamine agonist, is first-line for prolactinomas, shrinking tumors and normalizing prolactin. Rationale: Surgery (A) is for large/non-responsive tumors; Ondansetron (C) treats nausea, phenothiazine (D) increases prolactin, and antidepressants (E) are unrelated.